NCT05457608 is a NA clinical trial of Lens A in Presbyopia, sponsored by CooperVision, Inc..

Who is sponsoring NCT05457608?

NCT05457608 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT05457608?

Interventions in NCT05457608: Lens A, Lens B.

What condition does NCT05457608 study?

NCT05457608 studies Presbyopia.

Is NCT05457608 still recruiting?

NCT05457608 is currently completed. Last updated 20 December 2023.

Are results published for NCT05457608?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-12-20 · How we verify

NCT05457608

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Two Multifocal Contact Lenses

Completed NA Results posted Last updated 20 December 2023

What this trial tests

NA trial testing Lens A in Presbyopia in 42 participants. Completed in 13 August 2022.

Timeline

25 June 2022

Primary endpoint
13 August 2022

13 August 2022

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	42
Start date	25 June 2022
Primary completion	13 August 2022
Estimated completion	13 August 2022
Sites	1 location across Mexico

Drugs / interventions tested

Lens A
Lens B

Conditions studied

Presbyopia — all drugs for Presbyopia →

Sponsor

CooperVision, Inc.

Who can join

42 and older, any sex, with Presbyopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Subjective Comfort Ratings on Insertion Primary · At insertion

Subjective comfort ratings on insertion were measured on a scale from 0 - 10, where 0= extremely uncomfortable and 10= can't feel.

Group	Value	95% CI
Lens A	9.19	± 0.86
Lens B	9.47	± 0.67

Sponsor's own description

The aim of this study is to evaluate the patient subjective experiences of the monthly multifocal lens when compared to the daily disposable multifocal lens after 15 minutes of daily wear.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Human retinal secretome: A cross-link between mesenchymal and retinal cells.
Donato L, Scimone C, Alibrandi S, Scalinci SZ, et al · · 2023 · cited 6× · PMID 37545752 · DOI 10.4252/wjsc.v15.i7.665

Verify or expand the search:

Other trials of Lens A

Trials testing the same drug.

NCT05805085 — Clinical Evaluation of Hydrogel and Silicone Hydrogel Daily Disposable Toric Contact Lenses · NA · completed
NCT05688657 — Clinical Evaluation of Two Toric Contact Lenses · NA · completed
NCT05656885 — Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses · NA · completed
NCT05516082 — Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design · NA · completed
NCT04831515 — Performance Evaluation of Two Daily Disposable Toric Lens Designs in Habitual Soft Contact Lens Wearers · NA · completed

Other recruiting trials for Presbyopia

Currently open trials in the same condition.

NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05457608 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 20 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05457608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing